Cadherin Expression in Ovarian Carcinoma and Malignant Mesothelioma Cell Effusions
Overview
Affiliations
Objective: To analyze potential differences in cadherin expression between ovarian carcinoma/primary peritoneal carcinoma (OC/PPC) and malignant mesothelioma (MM) at this anatomic site.
Study Design: MM (N=24) and OC/PPC (N= 53) effusions were analyzed for E-cadherin, N-cadherin and P-cadherin protein expression using immunocytochemistry.
Results: Both MM and OC/PPC cells showed frequent expression of all 3 cadherins. OC/PPC specimens expressed E-cadherin and N-cadherin in 52 of 53 cases and P-cadherin in 51 of 53 cases. MM effusions expressed E-cadherin, N-cadherin and P-cadherin in 22 of 24, 21 of24 and 23 of24 cases, respectively. The differences in the percentage of cadherin-positive cells was weakly significant for P-cadherin (higher expression in MM, p = 0.04), but E-cadherin and N-cadherin expression was comparable (p > 0.05).
Conclusion: MM and OC/PPC coexpress different cadherin family members. P-cadherin, E-cadherin and N-cadherin are not useful for differentiation between OC/PPC and MM in effusions.
Gabbasov R, Xiao F, Howe C, Bickel L, OBrien S, Benrubi D Oncogene. 2018; 37(35):4854-4870.
PMID: 29773902 PMC: 6119087. DOI: 10.1038/s41388-018-0296-y.
Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.
Klymenko Y, Kim O, Stack M Cancers (Basel). 2017; 9(8).
PMID: 28792442 PMC: 5575607. DOI: 10.3390/cancers9080104.
Klymenko Y, Johnson J, Bos B, Lombard R, Campbell L, Loughran E Neoplasia. 2017; 19(7):549-563.
PMID: 28601643 PMC: 5497527. DOI: 10.1016/j.neo.2017.04.002.
Sheets J, Iwanicki M, Liu J, Howitt B, Hirsch M, Gubbels J Oncogenesis. 2016; 5(10):e264.
PMID: 27775699 PMC: 5117850. DOI: 10.1038/oncsis.2016.64.
Ko S, Naora H Mol Cancer. 2014; 13:170.
PMID: 25023983 PMC: 4105245. DOI: 10.1186/1476-4598-13-170.